small molecule glp 1 agonist Orforglipron, an Oral Small-Molecule GLP-1 Receptor for Obesity November 5, 2025 DOI: 10.1056/NEJMdo008238 New for the treatment of obesity - and so many additional indications being studied Potential oral small-molecule GLP-1R agonist.
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14


























